Increased soluble P-selectin following myocardial infarction: A new marker for the progression of atherosclerosis

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 7, 1997, Pages 383-390

  Blann, A D ^a   Faragher, E B ^b   McCollum, C N ^b  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Ischaemic heart disease; Soluble P selectin; von Willebrand factor

Indexed keywords

CHOLESTEROL; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PADGEM PROTEIN; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030680163     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199710000-00002     Document Type: Article

References (31)

1. Cahill MR, Newland AC. Platelet activation in coronary artery disease. Br J Biomed Sci 1993; 50: 221-234.
2. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro JH. Insights into the pathogenesis of acute ischemic syndromes. Circulation 1988; 77: 1213-1220.
3. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
4. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-434.
5. McEver RP. Selectins: novel receptors that mediate leukocyte adhesion during inflammation. Thromb Haemost 1991; 65: 223-228.
6. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha granule membrane protein (GMP140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101: 880-886.
7. Wagner DD. The Wiebel-Palade body: the storage granule for von Willebrand factor and P-selectin. Thromb Haemost 1993; 70: 105-110.
8. Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990; 75: 550-554.
9. Ikeda H, Nakayama H, Oda T, Kuwano K, Muraishi A, Sugi K, Koga Y, et al. Soluble form of P-selectin in patients with acute myocardial infarction. Coronary Artery Dis 1994; 5: 515-518.
10. Chong BH, Murray B, Berndt MC, Dunlop LC, Brighton T, Chesterman CN. Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood 1994; 83: 1535-1541.
11. Ikeda H, Takajo Y, Ichiki K, Ueno T, Maki S, Noda T, et al. Increased soluble form of P-selectin in patients with unstable angina. Circulation 1995; 92: 1693-1696.
12. Blann AD, Dobrotova M, Kubisz P, McCollum CN. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemost 1995; 74: 626-630.
13. Lip GYH, Blann AD, Zarifis J, Beevers M, Lip PL, Beevers DG. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report. J Hypertens 1995; 13: 1674-1678.
14. Jilma B, Fasching P, Ruthner C, Rumplmayr A, Ruzicka S, Kapiotis S, et al. Elevated circulating P-selectin in insulin dependent diabetes mellitus. Thromb Haemost 1996; 76: 328-332.
15. Blann AD. von Willebrand factor and the endothelium in vascular disease. Br J Biomed Sci 1993; 50: 125-134.
16. Badimon L, Badimon JJ, Chesebro JH, Fuster V. von Willebrand factor and cardiovascular disease. Thromb Haemost 1993; 70: 111-118.
17. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo J. Hemostatic factors and the risk of myocardial infarctrion or sudden death in patients with angina pcctoris. N Engl J Med 1995; 332: 635-641.
18. Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991; 665: 351-355.
19. Bernard R, Corday E, Eliasch H, Gonin A, Hiait R, Nikolaeva LF, et al. Nomenclature and criteria for diagnosis of ischaemic heart disease. Circulation 1979; 59: 607-609.
20. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull WHO 1962; 27: 645-658.
21. Cox DR. Regression models and life tables (with discussion). J Royal Stat Soc 1972; 34: 187-220.
22. McEver RP, Beckstead JH, Moore KL, Marshall Carlson L, Bainton DF. GMP-140, a platelet alpha granule membrane protein, is also synthesised by vascular endothelial cells and is localised in Weibel-Palade bodies. J Clin Invest 1989; 84: 92-99.
23. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93: 11877-11882.
24. Jilma B, Eichler HG, Vondrovec B, Breiteneder H, Kyrle PA, Kitzweger E, et al. Effects of desmopressin on circulating P-selectin. Br J Haematol 1996; 93: 432-436.
25. Takeda I, Kaise S, Nishimaki T, Kasukawa R. Soluble P-selectin in the plasma of patients with connective tissues diseases. Int Arch Allergy Immunol 1994; 105: 126-134.
26. Wu KK. Platelet activation mechanisms and markers in arterial thrombosis. J Int Med 1996; 239: 17-34.
27. Wong CS, Gamble JR, Skinner MP, Lucas CM, Berndt MC, Vadas MA. Adhesion protein GMP-140 inhibits superoxide anion release by human neutrophils. Proc Natl Acad Sci USA 1991; 88: 2397-2401.
28. Gamble JR, Skinner MP, Berndt MC, Vadas MA. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP-140. Science 1990; 249: 414-417.
29. Yokota T, Hansson GK. Immunological mechanisms in atherosclerosis. J Int Med 1995; 238: 479-489.
30. Johnston GI, Bliss GA, Newman PJ, McEver RP. Structure of the human gene encoding granule membrane protein 140, a member of the selectin family of adhesion receptors for leukocytes. J Biol Chem 1990; 34: 21381-21385.
31. Blann AD, Lip GYH. Hypothesis: is soluble P-selectin a new marker of platelet activation? Atherosclerosis 1997; 128: 135-138.